Dianthus Therapeutics Presents Future Outlook at Conference
Company Announcements

Dianthus Therapeutics Presents Future Outlook at Conference

Dianthus Therapeutics (DNTH) has shared an update.

Starting June 6, 2024, Dianthus Therapeutics, Inc. will unveil an updated corporate presentation at investor and analyst meetings, with CEO Marino Garcia showcasing it at the Jefferies Global Healthcare Conference. While the presentation includes forward-looking statements, these reflect potential risks and uncertainties that may lead to actual results differing from those projected. The provided information is for informational purposes and is not legally filed under securities laws.

For a thorough assessment of DNTH stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyDianthus reports Q3 EPS (74c), consensus (59c)
TheFlyDianthus initiated with an Outperform at Oppenheimer
TheFlyDianthus files $500M mixed securities shelf
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App